Glycogen storage disease type III as a model to study glycogen driving tumor development

Glycogen storage disease type III as a model to study glycogen driving tumor development

Glycogen storage disease type III as a model to study glycogen driving tumor development 1125 1625 Metabolism & Cancer
Pseudoprogression as a novel radiological sign of solid tumors underwent sonodynamic therapy
Lipid Metabolism supports the tumorigenic potential of Pancreatic Cancer Stem Cells
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here